Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified armed forces institute of pathology risk criteria

Annals of Surgical Oncology

Volumn 15, Issue 8, 2008, Pages 2153-2163

  Goh, Brian K P ^a   Chow, Pierce K H ^a,b   Yap, Wai Ming ^a   Kesavan, Sittampalam M ^a   Song, In Chin ^a   Paul, Pradeep G ^c   Ooi, Boon Swee ^a   Chung, Yaw Fui A ^a   Wong, Wai Keong ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c MINISTRY OF HEALTH   (Singapore)

Author keywords

Gastrointestinal stromal tumor; GIST; Prognosis; Risk criteria; Staging; Surgery

Indexed keywords

IMATINIB;

ADJUVANT THERAPY; ADULT; AGED; ARMED FORCES INSTITUTE OF PATHOLOGY; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOSIS RATE; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTOR VARIABLE; PROGNOSIS; RISK ASSESSMENT; SEROSA; STATISTICAL ANALYSIS; STRATIFICATION; SURVIVAL RATE; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 48149093474     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9969-z     Document Type: Article

References (26)

1. BL Eisenberg I Judson 2004 Surgery, imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy Ann Surg Oncol 11 465 75
2. S Hirota K Isozaki Y Moriyama 1998 Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors Science 279 577 80
3. M Gupta BC Sheppard CL Corless 2006 Outcome following surgical therapy for gastrointestinal stromal tumors J Gastrointest Surg 10 1099 105
4. EM Connolly E Gaffney JV Reynolds 2003 Gastrointestinal stromal tumors Br J Surg 90 1178 86
5. BK Goh PK Chow SM Kesavan 2008 Outcome after surgical treatment of suspected gastrointestinal stromal tumors involving the duodenum: is limited resection appropriate? J Surg Oncol 97 388 91
6. BK Goh PK Chow KL Chuah 2006 Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate Eur J Surg Oncol 32 961 3
7. CD Fletcher JJ Berman C Corless 2002 Diagnosis of gastrointestinal stromal tumors: a consensus approach Hum Pathol 33 459 65
8. M Miettinen W El-Rifai LH Sobin 2002 Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review Hum Pathol 33 478 83
9. M Miettinen LH Sobin J Lasota 2005 Gastrointestinal stromal tumors of the stomach. A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up Am J Surg Pathol 29 52 68
10. M Miettinen H Makhlouf LH Sobin 2006 Gastrointestinal stromal tumors of the jejunum and ileum. A clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up Am J Surg Pathol 30 477 89
11. M Miettinen J Lasota 2006 Gastrointestinal stromal tumors. Review on morphology, molecular pathology, prognosis, and differential diagnosis Arch Pathol Lab Med 130 1466 78
12. HY Huang CF Li WW Huang 2007 A modification of NIH consensus criteria to better distinguish the highly subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcome Surgery 141 748 56
13. P Rutkowski ZI Nowecki W Michej 2007 Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor Ann Surg Oncol 14 2018 27
14. B Nilsson P Bumming JM Meis-Kindblom 2005 Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden Cancer 103 821 9
15. I Ahmed NT Welch SL Parsons 2008 Gastrointestinal stromal tumors (GIST)-17 years experience from Mid Trent region (United Kingdom) Eur J Surg Oncol 34 445 9
16. I Hassan YN You R Shyyan 2008 Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis Ann Surg Oncol 15 52 9
17. Sobin LH, Wittekind C. International union against cancer: TNM classification of malignant tumours. 5th ed. New York: Wiley, 1997
18. JA Marrero RJ Fontana A Barrat 2005 Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort Hepatology 41 707 16
19. S Ueno G Tanabe K Sako 2001 Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients Hepatology 34 529 34
20. M Parzen SR Lipstiz 1999 A global goodness-fit statistic for Cox regression models Biometrics 55 580 4
21. RP Dematteo JJ Lewis D Leung 2000 Two hundred gastrointestinal stromal tumors. Recurrence patterns and prognostic factors for survival Ann Surg 231 51 8
22. I Pidhorecky RT Cheney WG Kraybill 2000 Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management Ann Surg Oncol 7 705 12
23. RP Dematteo MC Heinrich WM El-Rifai 2002 Clinical management of gastrointestinal stromal tumors: before and after STI-571 Hum Pathol 33 466 77
24. TS Emory LH Sobin L Lukes 1999 Prognosis of gastrointestinal stromal smooth-muscle (stromal) tumors. Dependence on anatomic site Am J Surg Pathol 23 82 7
25. EH Ng RE Pollock MM Romsdahl 1992 Prognostic implications of patterns of failure of gastrointestinal leiomyosarcomas Cancer 69 1334 41
26. EH Ng RE Pollock MF Munsell 1992 Prognostic factors influencing survival in gastrointestinal leiomyosarcomas: implications for surgical management and staging Ann Surg 215 68 77